Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Superior Treg-expanding properties of a novel dual-acting cytokine fusion protein, , , , , , , and . Frontiers in Pharmacology, (2019)Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism, , , , , , , , , and . Cell Death and Differentiation, (2020)Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism, , , , , , , , , and . Cell Death & Differentiation, 27 (8): 2417--2432 (February 2020)Selective activation of tumor necrosis factor receptor 2 induces anti-inflammatory responses and alleviates experimental arthritis, , , , , , , , , and 1 other author(s). Arthritis & Rheumatology, (January 2018)Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis, , , , , , , , , and 1 other author(s). Arthritis & rheumatology, 70 (5): 722-735 (2018)Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist, , , , , , , , , and . Cell death & disease, (2021)Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2, , , , , , , and . Scientific reports, (2017)Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion Protein, , , , , , , and . Frontiers in Pharmacology, (2019)